## Abstract A majority of malignant melanomas harbor an oncogenic mutation in either __BRAF__ or __NRAS__. If __BRAF__ and __NRAS__ transform melanoma cells by a similar mechanism, then additional genetic aberrations would be similar (or random). Alternatively, distinct mutationโassociated changes
Identification of novel regions of altered DNA copy number in small cell lung tumors
โ Scribed by Nikki A. Levin; Piur M. Bnorka; Martha L. Warnock; Joe W. Gray; Michael F. Christman
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 911 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Identification of the genetic alterations that occur in tumors is an important approach to understanding tumorigenesis. We have used comparative genomic hybridization (CGH), a novel molecular cytogenetic method, to identify the gross DNA copy number changes that commonly occur in small cell lung cancer (SCLC). We analyzed ten SCLC tumors (seven primary tumors and three metastases) from eight patients. We found frequent increases in DNA copy number on chromosome arms Sp, 8q, 3q, and Xq and frequent decreases in copy number on chromosome arms 3p. 17p, Sq, 8p, 13q, and 4p. The increase in copy number at 8q24 (MYC) and decreases at 17p 13 (TP53), 13q 14 (RB), and 3p have previously been identified in SCLC with other methods. Many of the other regions in which we detected common copy number changes have not been reported to be regions of common alteration in SCLC tumors. Comparison of copy number changes between a primary tumor and a metastasis from the same patient showed that they were more closely related to each other than to any of the other tumors. The results of direct CGH analysis of SCLC tumors reported here confirm the existence of copy number changes that we identified previously by using cell lines. ยฉ 1995 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
## Abstract Cisplatinโbased (CDDPโbased) adjuvant chemotherapy of nonโsmall cell lung cancer (NSCLC) was reported to yield 5โ15% improvement in 5โyear survival compared to complete resection alone. The importance of information concerning preselection of good responders has become increasingly evid
## Abstract The __HER2__ oncogene, which encodes the tyrosine kinase receptor, is commonly overexpressed in several types of cancer. Treatment using a humanized monoclonal antibody bound to __HER2__ product is becoming standard therapy for advanced breast cancer. Overexpression occurs in approximat
## Abstract Neurofibromatosis Type I (NF1) is an autosomal dominant disorder characterized by the development of both benign and malignant tumors. The lifetime risk for developing a malignant peripheral nerve sheath tumor (MPNST) in NF1 patients is โผ10% with poor survival rates. To date, the molecu